首页> 外文期刊>Frontiers in Pharmacology >Validation of a Case-Finding Algorithm for Identifying Patients with Non-small Cell Lung Cancer (NSCLC) in Administrative Claims Databases
【24h】

Validation of a Case-Finding Algorithm for Identifying Patients with Non-small Cell Lung Cancer (NSCLC) in Administrative Claims Databases

机译:在行政理赔数据库中识别非小细胞肺癌(NSCLC)患者的病例发现算法的验证

获取原文
           

摘要

Objective: To assess the validity of a treatments- and tests-based Case-Finding Algorithm for identifying patients with non-small cell lung cancer (NSCLC) from claims databases. Data sources: Primary data from the HealthCore Integrated Research Environment (HIRE)-Oncology database and the HealthCore Integrated Research Database (HIRD) were collected between June 1, 2014, and October 31, 2015. Study design: A comparative statistical evaluation using receiver operating characteristic (ROC) curve analysis and other validity measures was used to validate the NSCLC Case-Finding Algorithm vs. a control algorithm. Data collection: Patients with lung cancer were identified based on diagnosis and pathology classifications as NSCLC or small-cell lung cancer. Records from identified patients were linked to claims data from Anthem health plans. Three-month pre-index and post-index data were included. Principal findings: The NSCLC Case-Finding Algorithm had an area under the curve (AUC) of 0.88 compared with 0.53 in the control ( p < 0.0001). Promising diagnostic accuracy was observed for the NSCLC Case-Finding Algorithm based on sensitivity (94.8%), specificity (81.1%), positive predictive value (PPV) (95.3%), negative predictive value (NPV) (79.6%), accuracy (92.1%), and diagnostic odds ratio (DOR) (78.8). Conclusions: The NSCLC Case-Finding Algorithm demonstrated strong validity for distinguishing patients with NSCLC from those with SCLC in claims data records and can be used for research into NSCLC populations.
机译:目的:评估基于治疗和试验的案例发现算法从索赔数据库中识别非小细胞肺癌(NSCLC)患者的有效性。数据来源:2014年6月1日至2015年10月31日之间,收集了来自HealthCore集成研究环境(HIRE)-肿瘤学数据库和HealthCore集成研究数据库(HIRD)的主要数据。研究设计:使用接收者操作进行比较统计评估特征(ROC)曲线分析和其他有效性度量用于验证NSCLC案例查找算法与控制算法。数据收集:根据诊断和病理学分类将肺癌患者识别为NSCLC或小细胞肺癌。来自确定患者的记录与Anthem健康计划的索赔数据相关联。包括三个月的索引前和索引后数据。主要发现:NSCLC病例查找算法的曲线下面积(AUC)为0.88,而对照组为0.53(p <0.0001)。根据敏感性(94.8%),特异性(81.1%),阳性预测值(PPV)(95.3%),阴性预测值(NPV)(79.6%),准确性( 92.1%)和诊断优势比(DOR)(78.8)。结论:在索赔数据记录中,NSCLC病例查找算法证明了区分NSCLC患者和SCLC患者的强效性,可用于NSCLC人群的研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号